Prescott Group Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Sell |
2,034
-52
| -2% | -$53.1K | 0.21% | 122 |
|
|
2026
Q1 | $1.92M | Hold |
2,086
| – | – | 0.19% | 133 |
|
|
2025
Q4 | $2.24M | Hold |
2,086
| – | – | 0.21% | 133 |
|
|
2025
Q3 | $1.59M | Hold |
2,086
| – | – | 0.17% | 135 |
|
|
2025
Q2 | $1.63M | Buy |
2,086
+177
| +9% | +$138K | 0.19% | 137 |
|
|
2025
Q1 | $1.58M | Buy |
1,909
+309
| +19% | +$257K | 0.23% | 125 |
|
|
2024
Q4 | $1.24M | Hold |
1,600
| – | – | 0.17% | 156 |
|
|
2024
Q3 | $1.42M | Hold |
1,600
| – | – | 0.21% | 139 |
|
|
2024
Q2 | $1.45M | Hold |
1,600
| – | – | 0.23% | 125 |
|
|
2024
Q1 | $1.25M | Hold |
1,600
| – | – | 0.2% | 137 |
|
|
2023
Q4 | $933K | Hold |
1,600
| – | – | 0.16% | 133 |
|
|
2023
Q3 | $859K | Hold |
1,600
| – | – | 0.19% | 134 |
|
|
2023
Q2 | $750K | Hold |
1,600
| – | – | 0.16% | 136 |
|
|
2023
Q1 | $549K | Hold |
1,600
| – | – | 0.13% | 143 |
|
|
2022
Q4 | $585K | Hold |
1,600
| – | – | 0.13% | 141 |
|
|
2022
Q3 | $517K | Hold |
1,600
| – | – | 0.16% | 111 |
|
|
2022
Q2 | $519K | Hold |
1,600
| – | – | 0.14% | 118 |
|
|
2022
Q1 | $458K | Hold |
1,600
| – | – | 0.12% | 115 |
|
|
2021
Q4 | $442K | Hold |
1,600
| – | – | 0.1% | 157 |
|
|
2021
Q3 | $370K | Hold |
1,600
| – | – | 0.1% | 135 |
|
|
2021
Q2 | $367K | Hold |
1,600
| – | – | 0.1% | 118 |
|
|
2021
Q1 | $299K | Hold |
1,600
| – | – | 0.09% | 124 |
|
|
2020
Q4 | $270K | Sell |
1,600
-1,600
| -50% | -$239K | 0.08% | 97 |
|
|
2020
Q3 | $474K | Hold |
3,200
| – | – | 0.21% | 79 |
|
|
2020
Q2 | $525K | Hold |
3,200
| – | – | 0.26% | 69 |
|
|
2020
Q1 | $444K | Hold |
3,200
| – | – | 0.22% | 85 |
|
|
2019
Q4 | $421K | Hold |
3,200
| – | – | 0.15% | 111 |
|
|
2019
Q3 | $358K | Hold |
3,200
| – | – | 0.11% | 122 |
|
|
2019
Q2 | $355K | Hold |
3,200
| – | – | 0.09% | 134 |
|
|
2019
Q1 | $415K | Hold |
3,200
| – | – | 0.09% | 137 |
|
|
2018
Q4 | $370K | Hold |
3,200
| – | – | 0.07% | 179 |
|
|
2018
Q3 | $343K | Hold |
3,200
| – | – | 0.07% | 182 |
|
|
2018
Q2 | $273K | Hold |
3,200
| – | – | 0.05% | 194 |
|
|
2018
Q1 | $248K | Hold |
3,200
| – | – | 0.05% | 182 |
|
|
2017
Q4 | $270K | Hold |
3,200
| – | – | 0.06% | 163 |
|
|
2017
Q3 | $274K | Hold |
3,200
| – | – | 0.06% | 147 |
|
|
2017
Q2 | $263K | Hold |
3,200
| – | – | 0.06% | 151 |
|
|
2017
Q1 | $269K | Hold |
3,200
| – | – | 0.06% | 150 |
|
|
2016
Q4 | $235K | Hold |
3,200
| – | – | 0.05% | 145 |
|
|
2016
Q3 | $257K | Hold |
3,200
| – | – | 0.05% | 139 |
|
|
2016
Q2 | $252K | Hold |
3,200
| – | – | 0.06% | 135 |
|
|
2016
Q1 | $230K | Hold |
3,200
| – | – | 0.05% | 134 |
|
|
2015
Q4 | $270K | Hold |
3,200
| – | – | 0.06% | 151 |
|
|
2015
Q3 | $268K | Hold |
3,200
| – | – | 0.06% | 151 |
|
|
2015
Q2 | $267K | Hold |
3,200
| – | – | 0.05% | 174 |
|
|
2015
Q1 | $232K | Hold |
3,200
| – | – | 0.05% | 170 |
|
|
2014
Q4 | $221K | Hold |
3,200
| – | – | 0.04% | 212 |
|
|
2014
Q3 | $208K | Buy |
+3,200
| New | +$203K | 0.04% | 185 |
|
Other funds holding LLY
Prescott Group Capital Management's LLY Position: Q2 2026 in Review
Prescott Group Capital Management reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $53.1K and leaving 2,034 shares worth $2.44M. The position accounts for 0.21% of the portfolio, ranked #122.
Prescott Group Capital Management first reported a position in LLY in Q3 2014 and has held it in 48 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Prescott Group Capital Management held 2,034 shares of Eli Lilly worth $2.44M as of Q2 2026.
- Prescott Group Capital Management sold 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
- Eli Lilly made up 0.21% of Prescott Group Capital Management's portfolio in Q2 2026, its #122 holding.
- Prescott Group Capital Management first reported a position in Eli Lilly in Q3 2014 and has held it in 48 quarters since.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Prescott Group Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.